<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>I. Otte-Höller | Geert Litjens</title>
    <link>https://geertlitjens.nl/authors/i.-otte-h%C3%B6ller/</link>
      <atom:link href="https://geertlitjens.nl/authors/i.-otte-h%C3%B6ller/index.xml" rel="self" type="application/rss+xml" />
    <description>I. Otte-Höller</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>© 2019</copyright><lastBuildDate>Thu, 01 Apr 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://geertlitjens.nl/images/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_512x512_fill_lanczos_center_2.png</url>
      <title>I. Otte-Höller</title>
      <link>https://geertlitjens.nl/authors/i.-otte-h%C3%B6ller/</link>
    </image>
    
    <item>
      <title>Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics.</title>
      <link>https://geertlitjens.nl/publication/balk-21/</link>
      <pubDate>Thu, 01 Apr 2021 00:00:00 +0000</pubDate>
      <guid>https://geertlitjens.nl/publication/balk-21/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
